SCHEMBL23466880

SCHEMBL23466880

COc1cc(N2CCN(C3C4CC5CC3CC(O)(C5)C4)CC2)ccc1N

nearest known ligand 0.47

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ HSD11B1 P28845 15/20 0.40
▸ MAPT P10636 1/20 0.37
▸ CHEK1 O14757 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23480073 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HSD11B1MAPTCHEK1
SCHEMBL23479988 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HSD11B1MAPTCHEK1
SCHEMBL29851144 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2HSD11B1MAPTCHEK1
SCHEMBL23466890 0.86 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MAPTCHEK1
SCHEMBL23480080 0.86 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MAPTCHEK1
SCHEMBL23480135 0.84 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HSD11B1MAPTCHEK1
SCHEMBL29170979 0.84 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HSD11B1MAPTCHEK1
SCHEMBL23480041 0.84 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HSD11B1MAPTCHEK1
SCHEMBL29170982 0.83 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2HSD11B1MAPTCHEK1
SCHEMBL29170986 0.83 LMNA (0.45) ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114929675-B Adamantane derivatives as focal adhesion kinase inhibitors 三进制药株式会社 2024-02-13 — — CN disclosed
CN-114929675-A Novel adamantane derivatives as inhibitors of focal adhesion kinase 三进制药株式会社 2022-08-19 — — CN disclosed
WO-2021111311-A2 NOVEL ADAMANTANE DERIVATIVES AS INHIBITORS OF FOCAL ADHESION KINASE 삼진제약주식회사 2021-06-10 — — WO disclosed
Send feedback